CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 195 filers reported holding CYTOKINETICS INC in Q1 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $806 | -34.5% | 24,716 | -29.4% | 0.00% | -50.0% |
| Q1 2023 | $1,231 | -31.3% | 35,008 | -10.5% | 0.00% | 0.0% |
| Q4 2022 | $1,792 | -99.9% | 39,128 | -23.5% | 0.00% | -50.0% |
| Q3 2022 | $2,477,000 | -96.3% | 51,145 | -97.0% | 0.00% | -95.6% |
| Q2 2022 | $66,770,000 | +101066.7% | 1,699,426 | +94575.5% | 0.09% | – |
| Q1 2022 | $66,000 | +1550.0% | 1,795 | +1695.0% | 0.00% | – |
| Q4 2021 | $4,000 | +33.3% | 100 | 0.0% | 0.00% | – |
| Q3 2021 | $3,000 | -99.9% | 100 | -99.9% | 0.00% | -100.0% |
| Q1 2021 | $2,662,000 | -10.6% | 114,478 | -20.2% | 0.00% | -25.0% |
| Q4 2020 | $2,979,000 | -47.4% | 143,399 | -45.2% | 0.00% | -50.0% |
| Q3 2020 | $5,661,000 | -10.9% | 261,514 | -3.0% | 0.01% | -20.0% |
| Q2 2020 | $6,354,000 | – | 269,590 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
| Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
| Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
| Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
| GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
| Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
| PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
| DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
| Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
| Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |